HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pamela L Follett Selected Research

alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)

5/2004Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pamela L Follett Research Topics

Disease

2Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia)
05/2004 - 04/2002
1Cysts
04/2002
1Multiple Sclerosis
04/2002

Drug/Important Bio-Agent (IBA)

1Kainic Acid (Kainate)IBA
05/2004
1Topiramate (Topamax)FDA LinkGeneric
05/2004
1AMPA Receptors (AMPA Receptor)IBA
05/2004
1Kainic Acid Receptors (Kainate Receptor)IBA
05/2004
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
05/2004
1Glutamate Receptors (Glutamate Receptor)IBA
05/2004
1LipopolysaccharidesIBA
04/2002